Does Linvoseltamab Gcpt Interact with Cyp Substrates?
Linvoseltamab Gcpt and Cyp Substrates have a moderate drug interaction according to U.S. FDA drug labeling data. Linvoseltamab-gcpt causes cytokine release that may suppress CYP enzyme activity, increasing CYP substrate exposure and risk of adverse reactions. Monitoring for toxicity recommended. The mechanism involves cytokine-mediated suppression of cytochrome p450 enzyme activity. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Linvoseltamab Gcpt Class
- Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Linvoseltamab Gcpt and Cyp Substrates occurs because cytokine-mediated suppression of cytochrome p450 enzyme activity. Clinically, this means linvoseltamab-gcpt causes cytokine release that may suppress cyp enzyme activity, increasing cyp substrate exposure and risk of adverse reactions. monitoring for toxicity recommended. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Linvoseltamab Gcpt and your doctor is considering prescribing Cyp Substrates (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider